Stemtech

Stemtech Deferred Tax Liabilities

Deferred Tax Liabilities of Stemtech (STEK) as of Oct 19, 2026.

Deferred Tax Liabilities

-USD

Last updated:

Deferred Tax Liabilities of Stemtech is 2026 - USD. Deferred Tax Liabilities of Stemtech was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech Stock analysis

What does Stemtech do? Stemtech Corp, headquartered in Naples, Florida, develops nutritional supplements focused on supporting stem cell function. The company, listed on 15 September 2014, employs 45 full-time staff and operates internationally through subsidiaries and independent distributors. Its products, marketed under brands like RCM System, Stemflo MigraStem, and Cellect One Rapid Renew, enhance stem cell activity for health renewal. Segments include North America, Latin America, and Asia. Stemtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemtech stock

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Stemtech since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Stemtech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Stemtech

All Key Metrics — Stemtech